Skip to main content

Table 2 The pathways involved in differentially expressed genes compared with different time points following AMI

From: Potential biomarkers of acute myocardial infarction based on weighted gene co-expression network analysis

  Pathways Q-value (Q < 0.05)
admission versus control group Natural killer cell mediated cytotoxicity 3.142005e−09
Graft-versus-host disease 5.779472e−07
Antigen processing and presentation 2.997803e−03
Cytosolic DNA-sensing pathway 2.302012e−02
discharge versus control group Natural killer cell mediated cytotoxicity 8.154634e−10
Graft-versus-host disease 1.164728e−08
Antigen processing and presentation 1.657503e−04
Allograft rejection 2.438676e−02
admission versus 6 months Oxidative phosphorylation 3.841450e−15
Huntington’s disease 1.570003e−12
Parkinson’s disease 2.462576e−12
Alzheimer’s disease 1.076534e−11
discharge versus 6 months Parkinson’s disease 4.627948e−16
Oxidative phosphorylation 4.627948e−16
Alzheimer’s disease 9.071314e−15
Huntington’s disease 8.428429e−14